Alfred G. Merriweather, Chief Financial Officer at Adamas Pharmaceuticals Inc (ADMS), sold 1,665 shares at $19.18 ($32K) on 2018-09-21, disclosed to the SEC on 2018-09-21.
Open-market sale of $32k ADMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |